- Home
- GALT vs PINE Comparison
GALT vs PINE Comparison
Compare GALT & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- PINE
- Stock Information
- Founded
- GALT 2000
- PINE 2019
- Country
- GALT United States
- PINE United States
- Employees
- GALT N/A
- PINE N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- PINE Real Estate Investment Trusts
- Sector
- GALT Health Care
- PINE Real Estate
- Exchange
- GALT Nasdaq
- PINE Nasdaq
- Market Cap
- GALT 232.3M
- PINE 200.1M
- IPO Year
- GALT N/A
- PINE 2019
- Fundamental
- Price
- GALT $4.60
- PINE $15.47
- Analyst Decision
- GALT Strong Buy
- PINE Strong Buy
- Analyst Count
- GALT 3
- PINE 5
- Target Price
- GALT $6.00
- PINE $18.30
- AVG Volume (30 Days)
- GALT 241.8K
- PINE 71.8K
- Earning Date
- GALT 08-14-2025
- PINE 10-16-2025
- Dividend Yield
- GALT N/A
- PINE 7.37%
- EPS Growth
- GALT N/A
- PINE N/A
- EPS
- GALT N/A
- PINE N/A
- Revenue
- GALT N/A
- PINE $56,340,000.00
- Revenue This Year
- GALT N/A
- PINE $14.51
- Revenue Next Year
- GALT N/A
- PINE $0.12
- P/E Ratio
- GALT N/A
- PINE N/A
- Revenue Growth
- GALT N/A
- PINE 17.14
- 52 Week Low
- GALT $0.73
- PINE $13.95
- 52 Week High
- GALT $4.71
- PINE $19.29
- Technical
- Relative Strength Index (RSI)
- GALT 69.41
- PINE 66.02
- Support Level
- GALT $3.93
- PINE $15.10
- Resistance Level
- GALT $4.35
- PINE $15.33
- Average True Range (ATR)
- GALT 0.27
- PINE 0.24
- MACD
- GALT 0.03
- PINE 0.04
- Stochastic Oscillator
- GALT 91.67
- PINE 96.86
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.